Arcturus Therapeutics launches Phase I Avian Influenza trials in US
California vaccine company Arcturus Therapeutics has announced the launch of a Phase I trial of ARCT-2304, a self-amplifying mRNA (sa-mRNA) …
Post
-
-
IO Biotech enrols all subjects in Phase II trial of cancer combination therapy
Danish biotechnology company IO Biotech has finished enrolling subjects in a Phase II trial of its lead therapeutic cancer vaccine …
-
IMG Biosciences enacts massive lay-offs after Phase I trial failure
California-based biotech, IGM Biosciences, has put a halt to the development of two of its autoimmune disease therapies, imvotamab and …
-
Alentis Therapeutics reports positive results from organ fibrosis treatment trials
Swiss pharmaceutical company Alentis Therapeutics has reported positive topline outcomes from two clinical trials of its monoclonal antibody, lixudebart (ALE.F02), …
-
Sanofi reports positive results from trial of multiple myeloma drug candidate
French pharmaceutical company Sanofi has reported results from its Phase III IRAKLIA trial, which evaluated Sarclisa (isatuximab) as a potential …
-
South Korean study shows high prevalence of smoking among HIV patients
Among patients with human immunodeficiency virus (HIV) infection, smoking is associated with a higher risk of mortality and HIV-related complications. …
-
Alzheimer’s disease market expected to reach $19.3bn across the 8MM by 2033
The Alzheimer’s disease market is expected to grow at a high compound annual growth rate (CAGR) of 23.4% from $2.4bn …
-
Contineum concludes enrolment in Phase II multiple sclerosis therapy trial
Contineum Therapeutics has concluded the targeted enrolment of 168 subjects in its Phase II trial of M1 receptor antagonist PIPE-307 …
-
Cristcot‘s Phase III ulcerative colitis suppository trial meets endpoints
Massachusetts gastrointestinal disease firm, Cristcot, has announced results from its Phase III trial examining its hydrocortisone suppository and applicator for …
-
The impact of regulation and AI on Europe’s medical device trial landscape
In recent years, new regulation has been top-of-mind for medtech companies wishing to continue marketing their products in Europe. In …
-
Seasonal spike in HMPV causes public concern in China
A seasonal spike of human metapneumovirus (HMPV) is causing concern in Beijing. The virus, especially prevalent in children, typically leads …
-
Maat Pharma Phase III microbiome trial hits endpoints as stock soars
French clinical-stage biotechnology and microbiome therapy company MaaT Pharma has seen success with its Phase III trial of MaaT013 meeting …
-
Viking Therapeutics begins VK2735 Phase II trial for obesity treatment
Viking Therapeutics has announced the start of a Phase II clinical trial for VK2735, an oral tablet aimed at treating …
-
Suven doses first subjects in trial of SUVN-I6107 for cognitive disorders
India-based Suven Life Sciences has announced the dosing of the first subjects in its Phase I clinical trial of SUVN-I6107 …
-
Proposed self-screening tests for cervical cancer may drive increase in cases
Cervical cancer begins in the cells of the cervix and is primarily caused by the human papillomavirus (HPV), a common …
